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Primary CNS Melanoma
Kevin Leikert DO, Shravani Mikkilineni MD, Barry Skarf MD PhD
Henry Ford Health System, Detroit, Michigan
Patient Presentation
• 49-year-old female referred for bilateral disc edema
• Bilateral disc edema noted by an optometrist in April of 2018, associated with
a headache
• Referred to an ophthalmologist
• Has gained 20-30 lbs. in the last 4 years
• Saw an outside ophthalmologist, visual field showed some constriction in the
right eye
• Did not start diamox at that time, referred to neurology
• Neurology ordered an MRI and LP:
• MRI/MRV – Mild bilateral disc edema, no intracranial mass, no venous
thrombosis
• LP – opening pressure of 27
• Started her on Diamox 1000 mg BID, then decreased to 1000 mg AM and
500 mg PM due to not tolerating the diamox
• Returned to optometrist 2 weeks later with continued decreased peripheral
vision
• Discussed with neurology and increased diamox back to 1000 mg BID
• Referred to neuro-ophthalmology

Follow Up Imaging

Initial Imaging
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(2)

(4)

(3)

Figure 2: (1) MRI brain showing leptimeningeal enhancement (arrows) and nodularity
demonstrating some increased signaling on T1 without contrast, (2) Intrinsically T1
hyperintense, intramedullary mass centered at T2-T3 (circle)

Subsequent Course
• Laminectomy from C7 to T3 was performed on 07/19/2019
• Pathology confirmed metastatic melanoma
• Gait improved after debulking of tumor
• Full dermatologic exam revealed no other sites of melanoma
• Supports presumptive diagnosis of primary CNS melanoma
• Started on systemic chemotherapy per medical oncology
• Received one infusion
• Had a rapid decline and died on 8/25/19
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Diagnostic Considerations
Elevated disc margins
•
•
•
•
•
•
•

Pseudopapilledema
Disc Drusen
Malignant hypertension
Diabetic papillopathy
Hyperviscosity syndromes
Hypotension/blood loss
Early in the course of toxic optic
neuropathies

Elevated Intracranial Pressure
• Idiopathic intracranial hypertension
• Intracranial mass lesions
• Obstruction of venous outflow
• Venous sinus thrombosis
• Jugular vein compression
• Obstructive hydrocephalus
• Decreased CSF absorption
• Arachnoid granulation adhesions
after bacterial or other infectious
meningitis
• Subarachnoid hemorrhage
• Increased cerebrospinal fluid (CSF)
production
• Choroid plexus papilloma
• Malignant systemic hypertension

Workup for Bilateral Optic Disc Edema
• Full ophthalmologic exam
• Visual acuity
• Visual field testing
• Evaluation for afferent pupillary defect
• Color vision testing
• Dilated fundoscopic exam
• Optical coherence tomography (OCT) to quantify the elevation of the retinal
nerve fiber layer
• MRI/MRV and lumbar puncture6

Primary CNS Melanoma
Figure 1: (1) Optic disc pallor with surrounding watershed area, (2) Optic disc edema with hyperemia and
vessel obscuration (arrow), (3) OCT nerve showing diffuse optic atrophy in the right eye and elevated
retinal nerve fiber layer in the left eye, (4) Ganglion cell layer section of OCT showing significant atrophy
in the right eye and full ganglion cell layer in the left eye, (5) Humphrey visual field of the left eye
showing a full visual field (6) Humphrey visual filed of the right eye showing diffuse constriction with a
small infra-temporal island remaining
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Follow Up Visits
Date

1/14/19

including:7

3/28/19

6/20/19

Interval History

Exam

No changes in vision
Lost 8-10 lbs.
Taking Diamox
1000 mg BID

3+ APD OD
Full color plates
HVF unchanged
Optic atrophy OD with
possible refractile bodies
Persistent edema OS

No changes in vision
Headaches have improved
Lost 15 lbs.
Taking Diamox
1000 mg BID

Nausea and vomiting
Gait abnormalities
Taking Diamox
1000 mg BID

3+ APD OD
Full color plates
HVF unchanged
Optic atrophy OD
Persistent edema OS

Testing
Stable
RNFL and
GCL
on OCT

Stable
RNFL and
GCL
on OCT

3+ APD OD
Increased
Full color plates
elevation of
HVF early depression in
the RNFL on
the left eye
OCT in the
Optic atrophy OD
left eye
Persistent edema OS

•

Plan
FAF and B-scan: Negative
Decrease Diamox to
1000 mg AM and 500 mg
PM
Increase Diamox to
1500 AM and 1000 mg PM
Consider surgical
intervention
if no improvement
at next visit
Repeat MRI Brain and
lumbar puncture
Continue Diamox
1000 mg BID

Melanocytes exists in the uvea, cerebral parenchyma, leptomeninges, mucous
membranes, and skin3
Uncommon and constitute approximately 1% of all melanoma cases and 0.07% of all
brain tumors1,2
Primary cerebral melanomas often develop in patients under 50 years of age and
uncommonly metastasize to systemic organs
Hyperintense on T1 weighted images and hypointense on T2 weighted images due to
presence of melanin4
Once the cancer spreads to leptomeninges, the overall median survival is generally only
10 weeks5
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